611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hour Crisis Line
1-866-495-6735



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735


powered by centersite dot net
Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Cardiologist Calls for Action on Added SugarsCOPD May Be Over-Diagnosed Among UninsuredDigital Divide Exists With Physician EHR AdoptionDSM-4 Task Force Chairman Advises Caution With DSM-5Latest Edition of Psychiatry's 'Bible' Launched Amid ControversyMost Americans Say 'No' to Smoking in Their Homes, CarsCognitive Health Info From Doctors Found to Be Lacking'Nonsmoking' Hotel Rooms May Not Fully Protect GuestsUser Satisfaction With Electronic Health Records DownLook for New, Improved Sunscreen LabelsApplication for Health Coverage Has Been Simplified, ShortenedHospital Bills Can Vary Widely, Even in Same CitiesMoney Motivates Weight Loss -- One Step at a TimeFDA Proposes Tougher Warnings for Tanning BedsPotentially Toxic Metals Present in Lip CosmeticsPatients Most Annoyed by Long Waits, Unclear Test ResultsWhite House to Challenge Ruling on Unlimited Access to 'Morning-After' PillLipsticks, Glosses Contain Toxic Metals: ReportFDA Concerned Caffeinated Foods Could Harm ChildrenRenewed Efforts From AAFP to Repeal OTC Provision in ACAFDA Announces New Network to Focus Exclusively on PatientsPrescription Drug Take-Back Day Set for SaturdayHealth Insurance Shortfalls Hit Nearly Half of U.S. Adults: ReportAlmost Half of Americans Would Consider Donating Kidney to Stranger: PollPhysicians Less Empathetic in Talking to Heavy PatientsMost Americans Oppose Soda, Candy TaxesDiagnostic Errors Are the Leading Type of Malpractice ClaimAmerican Lung Association Stresses Clean Air Act BenefitsHospitalization OK for Psych Patients Can Take HoursU.S. Shortfall in Neurologists Expected to Get WorseUSPSTF: Primary Care Screening Can Help ID Suicide RiskU.S. Supreme Court Rejects Challenge to New Cigarette LabelingPatient-Centered Decision Making Ups Health OutcomesGuidelines Issued Relating to Online Medical ProfessionalismAlzheimer's Patients May Face Looming Shortage of NeurologistsClinical Trials Helped One Woman's Fight Against CancerSmoking Bans in Public Housing Could Save Dollars, Lives: CDCDoctors Order Fewer Lab Tests When They Know the CostDoctors' Insight Into Patients' Lives May Boost Care, Study FindsFDA Warns Against Sale of Sports Supplements in U.S.Most ED Docs, Nurses Doubtful About Suicide PreventabilityDoctors Urged to Refrain from Social Media Contacts With PatientsStrides Made in Preventing Cancer, But Challenges Remain: ReportDrug Company Reps Don't Tell Docs Enough About Side Effects: SurveyHospitals Work to Reduce Unnecessary Early BirthsMany Americans Skipping Meds to Save Money, CDC SaysFederal Judge Rules FDA Must Lift Restrictions on Plan BMental Health Care Lacking for Kids, Advocates SayMental Illness a Frequent Cell Mate for Those Behind BarsFed Gov to Cover 100% of New Medicaid Enrollees Under ACA
Questions and AnswersLinksBook Reviews
Related Topics

Health Insurance
Healthcare

AHA Recommends More Safeguards for Genetic Testing


HealthDay News
Updated: May 29th 2012

new article illustration

TUESDAY, May 29 (HealthDay News) -- While genetics show promise for improving health, more safeguards are needed to protect patients and allow scientific and clinical research to continue, according to recommendations issued by the American Heart Association and published online May 29 in Circulation.

Euan Ashley, D.Phil., from the Stanford University School of Medicine in California, and colleagues examined the moral, ethical, and legal challenges associated with use of genetic information in clinical medicine, the current regulatory landscape of genetic testing, and how genetic testing may impact cardiovascular medicine and research.

The researchers recommend that patents should no longer be awarded for observing a gene, such as the controversial Myriad Genetics Inc. patents for BRCA1 and BRCA2 to screen for breast and ovarian cancer risk. They also recommend that there be federal oversight of genetic tests and that antidiscrimination legislation be expanded beyond the 2008 Genetic Information Nondiscrimination Act. Other recommendations include the need for independent review to confirm the validity of genetic tests; specialized centers for genetic testing and counseling; a transparent, consistent, and evidence-based policy from the Centers for Medicare & Medicaid Services regarding payment for genetic testing; and more studies investigating genes that affect the risk of cardiovascular disease and response to drugs.

"The rapid pace of advancements in genetic technology offers great promise in its potential to transform patient care," Ashley and colleagues conclude. "We have laid out a framework to guide policy makers in the way we believe will best support our patients, as well as the scientists and physicians focused on cardiovascular health around the world."

Several authors disclosed financial ties to the health care and pharmaceutical industries. One author has provided expert testimony is cases pertaining to heart disease.

Full Text